产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 原料药 Semaglutide USF...

Semaglutide USFDA

2025-08-27
 元/克
910463-68-2
美国药典
Injection

产品详情

Semaglutide USFDA
心血管系统用药
910463-68-2
美国药典
Injection
Semaglutide Injection
中国,北美洲,中/南美洲,西欧,东欧,亚洲,中东,非洲

产品描述

Semaglutide(910463-68-2) is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to improved sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.

杭州耀泰生物技术有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

杭州耀泰生物技术有限公司是一家多年来以研发生产为基础,以市场为导向的新型高科技企业,主要研发生产并销售医药化工原料药及中间体。
业务类型:
成立日期:
年营业额:
主营产品类别: